BXRX - Baudax Bio announces $1.9M registered direct offering priced ATM
2023-08-17 08:33:07 ET
More on Baudax Bio
- Baudax Bio stock dips on pricing $4M stock offering at $1.15/share
- Baudax Bio stock surges ~40% as neuromuscular blocker BX1000 shows promise in trial
- Baudax rises after mid-stage data for neuromuscular blocking agent
- Baudax Bio jumps 70% after Phase 2 success for neuromuscular blocking agent
- Seeking Alpha’s Quant Rating on Baudax Bio
- Earnings data for Baudax Bio
For further details see:
Baudax Bio announces $1.9M registered direct offering priced ATM